Microsomal Glutathione S-transferase 1 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-85283
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the N-terminal region of human Microsomal Glutathione S-transferase 1. Peptide sequence: NPEDCVAFGKGENAKKYLRTDDRVERVRRAHLNDLENIIPFLGIGLLYSL The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for Microsomal Glutathione S-transferase 1 Antibody
Western Blot: Microsomal Glutathione S-transferase 1 Antibody [NBP2-85283]
Western Blot: Microsomal Glutathione S-transferase 1 Antibody [NBP2-85283] - WB Suggested Anti-MGST1 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: Human LiverApplications for Microsomal Glutathione S-transferase 1 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Microsomal Glutathione S-transferase 1
Alternate Names
glutathione S-transferase 12, GST12EC 2.5.1.18, MGC14525, MGST, MGST-I, microsomal glutathione S-transferase 1, Microsomal GST-1, Microsomal GST-I
Gene Symbol
MGST1
Additional Microsomal Glutathione S-transferase 1 Products
Product Documents for Microsomal Glutathione S-transferase 1 Antibody
Product Specific Notices for Microsomal Glutathione S-transferase 1 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...